TXG – 10x Genomics, Inc.
10x Genomics, Inc.TXG
$15.08Name : 10x Genomics, Inc.
Sector : Healthcare
Industry: Health Information Services
Mark. Cap: $1,825,494,272.00
EPSttm : -1.52
10x Genomics, Inc.
$15.08
0.07%$0.01Float Short %
6.59
Margin Of Safety %
-23
Put/Call OI Ratio
0.53
EPS Next Q Diff
0.11
EPS Last/This Y
1.52
EPS This/Next Y
0.05
Price
15.09
Target Price
20.13
Analyst Recom
2.3
Performance Q
-4.19
Relative Volume
0.69
Beta
1.84
Ticker: TXG
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | TXG | 13.61 | 0.39 | 1.50 | 7875 |
| 2024-12-20 | TXG | 14.06 | 0.36 | 1.04 | 7722 |
| 2024-12-23 | TXG | 14.79 | 0.44 | 0.03 | 4704 |
| 2024-12-24 | TXG | 14.67 | 0.41 | 3.36 | 4902 |
| 2024-12-26 | TXG | 14.68 | 0.45 | 0.16 | 5067 |
| 2024-12-27 | TXG | 14.61 | 0.45 | 0.58 | 5125 |
| 2024-12-30 | TXG | 14.35 | 0.44 | 0.33 | 5215 |
| 2024-12-31 | TXG | 14.37 | 0.44 | 0.17 | 5251 |
| 2025-01-02 | TXG | 14.18 | 0.44 | 0.05 | 5292 |
| 2025-01-03 | TXG | 15.61 | 0.44 | 0.92 | 5312 |
| 2025-01-06 | TXG | 15.93 | 0.44 | 0.35 | 5388 |
| 2025-01-07 | TXG | 15.52 | 0.43 | 0.81 | 5907 |
| 2025-01-08 | TXG | 15.83 | 0.45 | 0.89 | 6064 |
| 2025-01-09 | TXG | 15.83 | 0.45 | 0.85 | 6064 |
| 2025-01-10 | TXG | 15.58 | 0.44 | 1.05 | 6082 |
| 2025-01-13 | TXG | 15.72 | 0.50 | 0.33 | 6856 |
| 2025-01-14 | TXG | 15.43 | 0.51 | 1.09 | 6898 |
| 2025-01-15 | TXG | 15.05 | 0.52 | 0.72 | 7000 |
| 2025-01-16 | TXG | 15.09 | 0.53 | 0.68 | 7156 |
| 2025-01-17 | TXG | 15.09 | 0.53 | 0.35 | 7202 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | TXG | 13.61 | -286.3 | -12.9 | -0.66 |
| 2024-12-20 | TXG | 14.06 | -286.3 | -17.2 | -0.66 |
| 2024-12-23 | TXG | 14.73 | -286.3 | -20.8 | -0.66 |
| 2024-12-24 | TXG | 14.67 | -286.3 | -8.8 | -0.66 |
| 2024-12-26 | TXG | 14.67 | -286.3 | -9.8 | -0.66 |
| 2024-12-27 | TXG | 14.60 | -286.3 | -8.6 | -0.66 |
| 2024-12-30 | TXG | 14.35 | -286.3 | -6.0 | -0.66 |
| 2024-12-31 | TXG | 14.36 | -286.3 | -9.9 | -0.66 |
| 2025-01-02 | TXG | 14.19 | -286.3 | -6.9 | -0.66 |
| 2025-01-03 | TXG | 15.61 | -286.3 | -32.3 | -0.66 |
| 2025-01-06 | TXG | 15.94 | -286.3 | -14.5 | -0.66 |
| 2025-01-07 | TXG | 15.52 | -286.3 | -4.2 | -0.66 |
| 2025-01-08 | TXG | 15.83 | -286.3 | -13.9 | -0.66 |
| 2025-01-09 | TXG | 15.83 | -286.3 | -9.7 | -0.66 |
| 2025-01-10 | TXG | 15.58 | -286.3 | -6.2 | -0.66 |
| 2025-01-13 | TXG | 15.70 | -286.3 | -11.5 | -0.66 |
| 2025-01-14 | TXG | 15.42 | -286.3 | -9.2 | -0.66 |
| 2025-01-15 | TXG | 14.98 | -286.3 | -6.9 | -0.66 |
| 2025-01-16 | TXG | 15.07 | -286.3 | -15.0 | -0.66 |
| 2025-01-17 | TXG | 15.09 | -286.3 | -14.2 | -0.66 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | TXG | -0.12 | -0.95 | 6.92 |
| 2024-12-20 | TXG | -0.12 | -0.95 | 6.92 |
| 2024-12-23 | TXG | -0.12 | -0.95 | 6.92 |
| 2024-12-24 | TXG | -0.12 | -0.95 | 6.92 |
| 2024-12-26 | TXG | -0.13 | -0.95 | 6.19 |
| 2024-12-27 | TXG | -0.12 | -0.95 | 6.19 |
| 2024-12-30 | TXG | -0.13 | -0.91 | 6.19 |
| 2024-12-31 | TXG | -0.13 | -0.91 | 6.19 |
| 2025-01-02 | TXG | -0.12 | -0.91 | 6.19 |
| 2025-01-03 | TXG | -0.12 | -0.91 | 6.19 |
| 2025-01-06 | TXG | -0.11 | -0.84 | 6.19 |
| 2025-01-07 | TXG | -0.11 | -0.84 | 6.19 |
| 2025-01-08 | TXG | -0.12 | -0.84 | 6.19 |
| 2025-01-09 | TXG | -0.12 | -0.84 | 6.19 |
| 2025-01-10 | TXG | -0.12 | -0.84 | 6.19 |
| 2025-01-13 | TXG | -0.12 | -0.85 | 6.59 |
| 2025-01-14 | TXG | -0.13 | -0.85 | 6.59 |
| 2025-01-15 | TXG | -0.13 | -0.85 | 6.59 |
| 2025-01-16 | TXG | -0.13 | -0.85 | 6.59 |
| 2025-01-17 | TXG | -0.13 | -0.85 | 6.59 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.3
Avg. EPS Est. Current Quarter
-0.15
Avg. EPS Est. Next Quarter
-0.19
Insider Transactions
-0.13
Institutional Transactions
-0.85
Beta
1.84
Average Sales Estimate Current Quarter
153
Average Sales Estimate Next Quarter
142
Fair Value
11.63
Quality Score
44
Growth Score
50
Sentiment Score
25
Actual DrawDown %
92.8
Max Drawdown 5-Year %
-93.5
Target Price
20.13
P/E
Forward P/E
PEG
P/S
2.9
P/B
2.53
P/Free Cash Flow
70.1
EPS
-1.53
Average EPS Est. Cur. Y
-0.66
EPS Next Y. (Est.)
-0.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-28.99
Relative Volume
0.69
Return on Equity vs Sector %
-44.3
Return on Equity vs Industry %
-38.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.01
EBIT Estimation
-14.2
10x Genomics, Inc.Sector: Healthcare
Industry: Health Information Services
Employees: 1259
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading